skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,605  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: Clinical Medicine remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Testicular ultrasound inhomogeneity is an informative parameter for fertility evaluation
Testicular ultrasound inhomogeneity is an informative parameter for fertility evaluation
Material Type:
Article 		Add to My Research

Testicular ultrasound inhomogeneity is an informative parameter for fertility evaluation

Asian journal of andrology, 2020-05, Vol.22 (3), p.302-308 [Peer Reviewed Journal]

COPYRIGHT 2020 Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Shanghai Jiao Tong University ;COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. ;2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: ©The Author(s)(2019) 2019 ;ISSN: 1008-682X ;EISSN: 1745-7262 ;DOI: 10.4103/aja.aja_67_19 ;PMID: 31274478

Full text available

Citations Cited by
2
Fertility in Adolescents With Klinefelter Syndrome: A Survey of Current Clinical Practice
Fertility in Adolescents With Klinefelter Syndrome: A Survey of Current Clinical Practice
Material Type:
Article 		Add to My Research

Fertility in Adolescents With Klinefelter Syndrome: A Survey of Current Clinical Practice

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1883-e1891 [Peer Reviewed Journal]

Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2019 ;Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgz044 ;PMID: 31608942

Full text available

Citations Cited by
3
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Material Type:
Article 		Add to My Research

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Leukemia, 2017-11, Vol.31 (11), p.2443-2448 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2017 ;Macmillan Publishers Limited, part of Springer Nature. 2017. ;ISSN: 0887-6924 ;ISSN: 1476-5551 ;EISSN: 1476-5551 ;DOI: 10.1038/leu.2017.138 ;PMID: 28620163

Full text available

Citations Cited by
4
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Material Type:
Article 		Add to My Research

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

The New England journal of medicine, 2014-07, Vol.371 (5), p.424-433 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2014 Massachusetts Medical Society. All rights reserved. 2014 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1405095 ;PMID: 24881730 ;CODEN: NEJMAG

Full text available

Citations Cited by
5
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Material Type:
Article 		Add to My Research

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

Nature reviews. Endocrinology, 2020-03, Vol.16 (3), p.177-189 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-019-0310-7 ;PMID: 32020062

Full text available

Citations Cited by
6
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

The lancet oncology, 2022-01, Vol.23 (1), p.77-90 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00604-5 ;PMID: 34914889

Full text available

Citations Cited by
7
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Material Type:
Article 		Add to My Research

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

BMJ, 2020-05, Vol.369, p.m1849-m1849 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1849 ;PMID: 32409561

Digital Resources/Online E-Resources

Citations Cited by
8
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Material Type:
Article 		Add to My Research

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

New England Journal of Medicine, 2021-02, Vol.384 (6), p.497-511 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2023184 ;PMID: 33264556

Digital Resources/Online E-Resources

Citations Cited by
9
Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016
Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016
Material Type:
Article 		Add to My Research

Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016

Journal of investigative medicine, 2019-03, Vol.67 (3), p.699-705 [Peer Reviewed Journal]

American Federation for Medical Research 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 American Federation for Medical Research ;2019 American Federation for Medical Research 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1081-5589 ;EISSN: 1708-8267 ;DOI: 10.1136/jim-2018-000823 ;PMID: 30368484

Full text available

Citations Cited by
10
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Material Type:
Article 		Add to My Research

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Lancet neurology, 2021-08, Vol.20 (8), p.653-670 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00095-8 ;PMID: 34139157

Full text available

Citations Cited by
11
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
Material Type:
Article 		Add to My Research

Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms

The New England journal of medicine, 2020-08, Vol.383 (9), p.874-882 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMms2004740 ;PMID: 32853499

Full text available

Citations Cited by
12
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

The Lancet (British edition), 2021-01, Vol.397 (10272), p.375-386 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 2589-7500 ;EISSN: 1474-547X ;EISSN: 2589-7500 ;DOI: 10.1016/S0140-6736(20)32714-8 ;PMID: 33485464

Full text available

Citations Cited by
13
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.702-715 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00079-6 ;PMID: 33862000

Full text available

Citations Cited by
14
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Material Type:
Article 		Add to My Research

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

The New England journal of medicine, 2020-05, Vol.382 (20), p.1894-1905 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915745 ;PMID: 32402160

Full text available

Citations Cited by
15
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2021-02, Vol.22 (2), p.256-266 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30599-4 ;PMID: 33476595

Full text available

Citations Cited by
16
Severe Covid-19
Severe Covid-19
Material Type:
Article 		Add to My Research

Severe Covid-19

New England Journal of Medicine, 2020-12, Vol.383 (25), p.2451-2460 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcp2009575 ;PMID: 32412710

Digital Resources/Online E-Resources

Citations Cited by
17
EULAR recommendations for the management of antiphospholipid syndrome in adults
EULAR recommendations for the management of antiphospholipid syndrome in adults
Material Type:
Article 		Add to My Research

EULAR recommendations for the management of antiphospholipid syndrome in adults

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1296-1304 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215213 ;PMID: 31092409

Full text available

Citations Cited by
18
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Material Type:
Article 		Add to My Research

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet (British edition), 2019-08, Vol.394 (10196), p.385-395 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31131-6 ;PMID: 31227373

Full text available

Citations Cited by
19
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Material Type:
Article 		Add to My Research

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

The lancet oncology, 2020-01, Vol.21 (1), p.162-174 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30684-9 ;PMID: 31806540

Full text available

Citations Cited by
20
Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions
Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions
Material Type:
Article 		Add to My Research

Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions

PloS one, 2010-12, Vol.5 (12), p.e15941-e15941 [Peer Reviewed Journal]

COPYRIGHT 2010 Public Library of Science ;COPYRIGHT 2010 Public Library of Science ;2010 Schäfer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Schäfer et al. 2010 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0015941 ;PMID: 21209965

Full text available

Citations Cited by

Results 1 - 20 of 5,605  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1995  (10)
  2. 1995 To 2001  (46)
  3. 2002 To 2008  (410)
  4. 2009 To 2016  (1,950)
  5. After 2016  (3,192)
  6. More options open sub menu

Subject 

  1. Male  (5,487)
  2. Humans  (5,484)
  3. Science & Technology  (5,295)
  4. Female  (5,114)
  5. Life Sciences & Biomedicine  (4,153)
  6. Middle Aged  (3,894)
  7. Aged  (3,183)
  8. Adult  (2,864)
  9. Studies  (1,324)
  10. Hospitals  (1,320)
  11. Aged, 80 And Over  (1,267)
  12. Multidisciplinary Sciences  (1,136)
  13. Science & Technology - Other Topics  (1,136)
  14. Medicine  (1,109)
  15. Risk Factors  (1,100)
  16. Treatment Outcome  (1,083)
  17. Mortality  (1,018)
  18. Retrospective Studies  (983)
  19. More options open sub menu

Language 

  1. English  (5,604)
  2. Japanese  (594)
  3. Norwegian  (27)
  4. Portuguese  (5)
  5. French  (2)
  6. Swedish  (1)
  7. Arabic  (1)
  8. Persian  (1)
  9. German  (1)
  10. Chinese  (1)
  11. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait